BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Natural Alternatives International, Inc. Announces 2019 Q2 and YTD Results

  Natural Alternatives International, Inc. announced net income of $2.2 million, or $0.31 per diluted share, on net sales of $36.0 million for the quarter ended December 31, 2018.

  February 12, 2019

   · 

  8 min read
• Business

  Electromed, Inc. Announces Fiscal 2019 Second Quarter Financial Results

  Electromed, Inc. announced financial results for the three months ended December 31, 2018 (Q2 FY 2019).

  February 12, 2019

   · 

  10 min read
• Pharm Country

  Survey: 1 in 4 Millennials Plan to Buy Experience Gifts for Valentine’s Day, Shows New Study by Xperience Days

  In a Valentine’s Day survey conducted by Xperience Days on over 500 Americans regarding gift-giving habits, half of the respondents revealed they’re not as excited about the holiday as they once were.

  February 12, 2019

   · 

  2 min read
• Policy

  Harmony Biosciences Announces File Acceptance Of Its New Drug Application For Pitolisant

  Harmony Biosciences, LLC announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for its investigational product, pitolisant, and has granted Priority Review for this NDA.

  February 12, 2019

   · 

  4 min read
• Policy

  /C O R R E C T I O N from Source -- Liberty Health Sciences/

  In the news release, “Liberty Health Sciences Announces Independent Findings in Response to Short Seller Allegations and Further Strategic Changes”, issued Feb. 12, 2019 by Liberty Health Sciences Inc.

  February 12, 2019

   · 

  7 min read
• Pharm Country

  Health Canada Keynote at the 17th Cold Chain Global Forum Canada

  IQPC is pleased to announce the new Keynote speaker for the 17th Cold Chain Global Forum Canada!

  February 12, 2019

   · 

  1 min read
• Pharm Country

  Feinstein CEO, global researchers demonstrate significance of neurotransmitter in viral infection - February 12, 2019

  Feinstein Institute for Medical Research President and CEO Kevin J. Tracey, MD has joined with leading scientists across Canada, Europe and Asia, to discover the critical role the chemical acetylcholine plays as a neurotransmitter in combating chronic viral infection, as published online today in Science.

  February 12, 2019

   · 

  2 min read
• Business

  Bio-Rad to Report Fourth-Quarter and Full-Year 2018 Financial Results Thursday, February 28, 2019

  Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2018 on Thursday, February 28, 2019, following the close of the market.

  February 12, 2019

   · 

  1 min read
• Business

  Poseidon Water CEO Carlos Riva Responds to California Governor Gavin Newsom’s State of the State Address

  Poseidon Water CEO Carlos Riva today issued a statement in response to Governor Gavin Newsom’s State of the State Address.

  February 12, 2019

   · 

  1 min read
• Policy

  MIT Releases New Policy and Practice Suggestions to Make Cures Accessible and Sustainable

  Innovative Therapies Will Require Innovations in Financing and Regulations

  February 12, 2019

   · 

  3 min read